U.S. Food and Drug Administration

Dockets logo

FR Home ] Dockets Home ] [ FDA Home Page ]



Federal Register

Vol. 69 , No.

Wednesday, September 29, 2004

Contents (TXT)  (PDF)

Documents and comments received by the Dockets Management Branch "MAY" be posted on the Internet. Please "DO NOT INCLUDE" personal identifying information, i.e. date of birth, social security number, medical information, etc., in your correspondence. Documents are on display for public inspection at the Dockets Management Branch,  5630 Fishers Lane - Room 1061- HFA-305, Rockville, MD, 20852; 301-827-6860; TTY/TDD Users 1-800-735-2258.


NOTICES

Docket No. 2003N-0565, OC 2004234.  Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Generic Food and Drug Administration Rapid Response Surveys.  Pages  58175-58176 [FR Doc. 04-21748]  [TXT] [PDF] [PRE-PUB] OMB approval no. 0910-0500 expires on February 28, 2006
Supporting Statement Word Version
Supporting Statement PDF Version

Docket No. 2003E-0033, CDER 2004122.  Determination of Regulatory Review Period for Purposes of Patent Extension; DERMAGRAFT.  Pages  58176-58177 [FR Doc. 04-21749]  [TXT] [PDF] [PRE-PUB] Comments due November 29, 2004

Docket No. 2004N-0017, OC 2004238.  Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Adverse Event Pilot Program for Medical Devices.  Page  58176 [FR Doc. 04-21750]  [TXT] [PDF] [PRE-PUB] OMB Approval No. 0910-0471 Expires September 30, 2007

Supporting Statement Word Version
Supporting Statement PDF Version


Top ] FR Home ] Dockets Home ] [ FDA Home Page ]